Latest Elekta B Shs (EKTAF) Headlines Elekta
Post# of 5
Posted On: 03/09/2014 5:32:16 PM
Latest Elekta B Shs (EKTAF) Headlines
Elekta reports number of share
M2 - Mon Mar 03, 4:26AM CST
Human care company Elekta AB (STO:EKTAB) announced on Friday that, as of 28 February 2014, the total number of shares in the company amounted to 382,828,564, of which 14,250,000 are A-shares and 368,578,564 are B-shares.
Elekta revises outlook for fiscal year 2013/14
M2 - Mon Feb 24, 5:52AM CST
Swedish radiation therapy company Elekta AB (STO:EKTAB.ST) reported on Friday EBITA of SEK340m for Q3 of fiscal 2013/2014.
Radware Releases Defense4All, Industry-First Open SDN Security Application for OpenDaylight Project
GlobeNewswire - Tue Feb 04, 4:30AM CST
[OPEN DAYLIGHT SUMMIT] -- Radware(Nasdaq:RDWR), a leading provider of application delivery and application security solutions for virtual and cloud data centers, today announced its contribution to the OpenDaylight Project with Defense4All, the industry's first open SDN security application to be integrated into OpenDaylight.
Elekta awarded USD16m contract to deliver cancer care solutions to Iraq
M2 - Fri Jan 24, 6:36AM CST
Human care company Elekta AB (STO:EKTAB) announced today the receipt of an order from Iraq for state-of-the-art radiation therapy equipment.
Global Radiation Therapy Equipment Strategic Business Report 2018: Linear Accelerator, Treatment Planning & Radiation Therapy Simulator Analysis
M2 - Thu Jan 09, 10:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/g3kn9n/radiation_therapy#summary) has announced the addition of the "Radiation Therapy Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, Middle East and Africa, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: - Linear Accelerator - Treatment Planning Systems - Radiation Therapy Simulator The report profiles 45 companies including many key and niche players such as: - Accuray Inc. - BrainLab - Elekta AB - GE Healthcare - Hitachi America - IBA Group Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends & Issues 3. Proton Therapy - An Insight 4. Competition 5. Cancer - A Global Concern 6. Radiation Therapy: An Overview 7. Product Overview 8. Radiotherapy Accessories 9. Cancer Therapy - Epidemiology 10. Cancer Treatment - A Cost Analysis 11. New Frontiers In Radiation Therapy 12. Product Innovations/Introductions 13. Recent Industry Activity 14. Focus On Select Key Players 15. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East And Africa 7. Latin America IV. Competitive Landscape Total Companies Profiled: 45 (including Divisions/Subsidiaries - 54) - The United States (24) - Canada (3) - Japan (4) - Europe (19) - - France (1) - - Germany (6) - - The United Kingdom (1) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (2) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/g3...py#summary
Elekta awarded USD28m order to provide cancer care solutions to China
M2 - Fri Jan 03, 5:56AM CST
Human care company Elekta AB (STO:EKTAB) announced on Thursday the receipt of an order by China's Health Department of the People's Liberation Army (PLA) of a comprehensive range of its clinical solutions for managing cancer.
Elekta's Versa HD system boosts radiotherapy speed and precision in first patient treatments at clinic in Germany
M2 - Fri Dec 27, 5:03AM CST
Human care company Elekta AB (STO:EKTAB.ST) announced on Thursday that on 28 October 2013, clinicians at Evangelische Kliniken Gelsenkirchen (Gelsenkirchen, Germany) launched a new era of radiation therapy speed and accuracy with its first Versa HD case, a 72-year-old female patient with advanced (metastatic) cancer.
Brachytherapy Devices Worldwide Market Report 2013-2016
M2 - Fri Nov 01, 6:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/52pl6c/global) has announced the addition of the "Brachytherapy Devices Worldwide Market Report 2013-2016" report to their offering. Analysts forecast the brachytherapy devices market to grow at a CAGR of 2.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant increase in the number of cancer patients worldwide. The Global Brachytherapy Devices market has also been witnessing a significant increase in the number of acquisitions. However, alternatives for cancer treatment could pose a challenge to the growth of this market. The report, Brachytherapy Devices Worldwide Market Report 2013-2016, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Brachytherapy Devices market landscape and its growth prospects in the coming years. Key questions answered in this report: - What will the market size be in 2016 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? - You can request one free hour of analyst time when you purchase this report. Details provided within the report. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Key Leading Countries 7. Rate of Incidence and Prevalence 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and Their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned - Boston Scientific - C.R. Bard - CIVCO Medical Instruments - CONMED - Cook Medical - Eckert & Ziegler BEBIG - Elekta AB - GE Healthcare - Gammex - Huiheng Medical - Olympus - Theragenics - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/52pl6c/global
Elekta names Niklas Savander as new President and CEO
M2 - Fri Oct 25, 5:53AM CDT
Human care company Elekta AB (STO:EKTAB) announced today the appointment of Niklas Savander as the company's president and chief executive officer, effective 1 May 2014.
Elekta mutually resolves lawsuit against Varian Medical Systems
M2 - Tue Aug 13, 5:04AM CDT
Human care company Elekta AB (STO:EKTAB.ST) reported today that the lawsuit, announced in August 2012, against Varian Medical Systems has been resolved by mutual agreement by the parties.
Welcome to the Annual General Meeting of shareholders of Elekta AB (publ)
Business Wire - Mon Aug 05, 1:00AM CDT
Shareholders of Elekta AB (publ) are hereby invited to attend the Annual General Meeting to be held on Tuesday, September 3, 2013, at 3:00 pm at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4 in Stockholm. Registration will commence at 2:00 pm.
Radiation Therapy Equipment - Global Strategic Business Report 2012-2018 - Replacement Sales Spur Global Radiotherapy Market
M2 - Thu Jun 27, 6:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vx7xss/radiation_therapy) has announced the addition of the "Radiation Therapy Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. A Six-year historic analysis is also provided for these markets. This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: - Linear Accelerator - Treatment Planning Systems - Radiation Therapy Simulator. The report profiles 55 companies including many key and niche players such as: - Accuray Incorporated - Elekta AB - Nucletron B.V. - Nordion, Inc. - Philips Healthcare - Siemens Healthcare - Varian Medical Systems, Inc. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. Executive Summary 1. MARKET OVER
Elekta reports number of share
M2 - Mon Mar 03, 4:26AM CST
Human care company Elekta AB (STO:EKTAB) announced on Friday that, as of 28 February 2014, the total number of shares in the company amounted to 382,828,564, of which 14,250,000 are A-shares and 368,578,564 are B-shares.
Elekta revises outlook for fiscal year 2013/14
M2 - Mon Feb 24, 5:52AM CST
Swedish radiation therapy company Elekta AB (STO:EKTAB.ST) reported on Friday EBITA of SEK340m for Q3 of fiscal 2013/2014.
Radware Releases Defense4All, Industry-First Open SDN Security Application for OpenDaylight Project
GlobeNewswire - Tue Feb 04, 4:30AM CST
[OPEN DAYLIGHT SUMMIT] -- Radware(Nasdaq:RDWR), a leading provider of application delivery and application security solutions for virtual and cloud data centers, today announced its contribution to the OpenDaylight Project with Defense4All, the industry's first open SDN security application to be integrated into OpenDaylight.
Elekta awarded USD16m contract to deliver cancer care solutions to Iraq
M2 - Fri Jan 24, 6:36AM CST
Human care company Elekta AB (STO:EKTAB) announced today the receipt of an order from Iraq for state-of-the-art radiation therapy equipment.
Global Radiation Therapy Equipment Strategic Business Report 2018: Linear Accelerator, Treatment Planning & Radiation Therapy Simulator Analysis
M2 - Thu Jan 09, 10:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/g3kn9n/radiation_therapy#summary) has announced the addition of the "Radiation Therapy Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, Middle East and Africa, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: - Linear Accelerator - Treatment Planning Systems - Radiation Therapy Simulator The report profiles 45 companies including many key and niche players such as: - Accuray Inc. - BrainLab - Elekta AB - GE Healthcare - Hitachi America - IBA Group Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends & Issues 3. Proton Therapy - An Insight 4. Competition 5. Cancer - A Global Concern 6. Radiation Therapy: An Overview 7. Product Overview 8. Radiotherapy Accessories 9. Cancer Therapy - Epidemiology 10. Cancer Treatment - A Cost Analysis 11. New Frontiers In Radiation Therapy 12. Product Innovations/Introductions 13. Recent Industry Activity 14. Focus On Select Key Players 15. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East And Africa 7. Latin America IV. Competitive Landscape Total Companies Profiled: 45 (including Divisions/Subsidiaries - 54) - The United States (24) - Canada (3) - Japan (4) - Europe (19) - - France (1) - - Germany (6) - - The United Kingdom (1) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (2) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/g3...py#summary
Elekta awarded USD28m order to provide cancer care solutions to China
M2 - Fri Jan 03, 5:56AM CST
Human care company Elekta AB (STO:EKTAB) announced on Thursday the receipt of an order by China's Health Department of the People's Liberation Army (PLA) of a comprehensive range of its clinical solutions for managing cancer.
Elekta's Versa HD system boosts radiotherapy speed and precision in first patient treatments at clinic in Germany
M2 - Fri Dec 27, 5:03AM CST
Human care company Elekta AB (STO:EKTAB.ST) announced on Thursday that on 28 October 2013, clinicians at Evangelische Kliniken Gelsenkirchen (Gelsenkirchen, Germany) launched a new era of radiation therapy speed and accuracy with its first Versa HD case, a 72-year-old female patient with advanced (metastatic) cancer.
Brachytherapy Devices Worldwide Market Report 2013-2016
M2 - Fri Nov 01, 6:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/52pl6c/global) has announced the addition of the "Brachytherapy Devices Worldwide Market Report 2013-2016" report to their offering. Analysts forecast the brachytherapy devices market to grow at a CAGR of 2.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant increase in the number of cancer patients worldwide. The Global Brachytherapy Devices market has also been witnessing a significant increase in the number of acquisitions. However, alternatives for cancer treatment could pose a challenge to the growth of this market. The report, Brachytherapy Devices Worldwide Market Report 2013-2016, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Brachytherapy Devices market landscape and its growth prospects in the coming years. Key questions answered in this report: - What will the market size be in 2016 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? - You can request one free hour of analyst time when you purchase this report. Details provided within the report. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Key Leading Countries 7. Rate of Incidence and Prevalence 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and Their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned - Boston Scientific - C.R. Bard - CIVCO Medical Instruments - CONMED - Cook Medical - Eckert & Ziegler BEBIG - Elekta AB - GE Healthcare - Gammex - Huiheng Medical - Olympus - Theragenics - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/52pl6c/global
Elekta names Niklas Savander as new President and CEO
M2 - Fri Oct 25, 5:53AM CDT
Human care company Elekta AB (STO:EKTAB) announced today the appointment of Niklas Savander as the company's president and chief executive officer, effective 1 May 2014.
Elekta mutually resolves lawsuit against Varian Medical Systems
M2 - Tue Aug 13, 5:04AM CDT
Human care company Elekta AB (STO:EKTAB.ST) reported today that the lawsuit, announced in August 2012, against Varian Medical Systems has been resolved by mutual agreement by the parties.
Welcome to the Annual General Meeting of shareholders of Elekta AB (publ)
Business Wire - Mon Aug 05, 1:00AM CDT
Shareholders of Elekta AB (publ) are hereby invited to attend the Annual General Meeting to be held on Tuesday, September 3, 2013, at 3:00 pm at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4 in Stockholm. Registration will commence at 2:00 pm.
Radiation Therapy Equipment - Global Strategic Business Report 2012-2018 - Replacement Sales Spur Global Radiotherapy Market
M2 - Thu Jun 27, 6:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vx7xss/radiation_therapy) has announced the addition of the "Radiation Therapy Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. A Six-year historic analysis is also provided for these markets. This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: - Linear Accelerator - Treatment Planning Systems - Radiation Therapy Simulator. The report profiles 55 companies including many key and niche players such as: - Accuray Incorporated - Elekta AB - Nucletron B.V. - Nordion, Inc. - Philips Healthcare - Siemens Healthcare - Varian Medical Systems, Inc. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. Executive Summary 1. MARKET OVER
(0)
(0)Elekta B Shs (EKTAF) Stock Research Links
Scroll down for more posts ▼